BIOBank acquires Neutromedics AG

BIOBank, a French human origin bone bank, has acquired Neutromedics AG, a Swiss distributor of orthobiologics and orthopedic implants. This is BIOBank's first external growth transaction.

“BIOBank, a portfolio company of the growth equity fund NewAlpha Verto and of a fund managed by Capital Croissance, accelerates its international development with this first external growth transaction.”datenmarkt.de

• 1 source
• datenmarkt.deBIOBank übernimmt Neutromedics AG – datenmarkt.deSvenja ScheuermannJan 13, 2020

Summarized from public sources; check the original articles before acting on it.